Volatile APAC and cost base negatively impacting Q2 We expect FY’22 EBITDA guidance to be under pres...
Cut to Q2e on lagged price increases and softer demand We cut ’22e-’24e EBITA by 6-5%, on tougher e...
Redeye ger en kort kommentar om morgonens nyhet om fas IIb-studien med Mesdopetam.
We keep our estimates unchanged ahead of Q2 Higher uncertainty for retailers, but long-term case int...
Q1 var ett händelserikt kvartal för Metacon som bland annat inledde sin kommersialiseringsfas och in...
Redeye has a positive take on the news that Antti Vuolanto, currently COO, has been named as CEO of ...
The consumer demand for durable goods in the Nordic markets has continued softly in Q2 and hence we ...
Redeye updates its estimates for Q2. Sales estimates are raised mainly due to FX tailwind and the in...
Redeye is encouraged by TH1NG announcing a first and significant agreement as an IoT supplier in ind...
Q2 report due on July 28 We expect sales of EUR 309m and adj.
Estimattrenden verkar ha planat ut... Instalcos aktie har gått sämre än peers sedan universet toppad...
Redeye continues to have a positive outlook on Waystream even after a slightly weaker report than we...
Redeye is reflecting on Inzile’s Strategic Plan 2022-24 and other recent events.
Q2e EBIT of SEK 159m Pulp prices at ATH, but more supply into ‘23e Fair value range of SEK 10-15/sha...
Beijer Alma meddelar att man ingått avtal om att avyttra dotterbolaget Habia Cable till tyska HEW-KA...
Redeye ser positivt på nyheten att FDA accepterat Eisais registreringsansökan för Lecanemab under de...
Both CEPS and NAV trimmed by ~1-3% Relatively good funding conditions and low LTV Trading at ~40% ...
Q2 report due on 15 July We expect sales of SEK 444m and EBITA of 66m We lower our ’23-24e EBITA by ...
Q2 report due on July 19 We expect sales of SEK 190m and adj.
Redeye comments on the outcome of Scandion’s rights issue, and we resume our coverage.
